About NAVROGEN INC
Navrogen is a biotechnology company focused on developing therapeutic agents and diagnostic tools to overcome immunosuppressive mechanisms in humoral immuno-oncology. The company is advancing a pipeline of antibody-drug conjugates and next-generation antibodies targeting tumor-related factors.
Development of therapeutic agents targeting immunosuppressive pathways in humoral immunityCreation of diagnostic tools to identify tumor factors affecting humoral immune responsesDesign of antibody-drug conjugates refractory to immunosuppressive factors (e.g., NAV-001, NAV-006)Innovation in next-generation antibody formats with enhanced effector functions
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to NAVROGEN INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.